San Donato Milanese

Italy

60 total trials 33 recruiting

Filter these 60 trials by phase, condition, sponsor and more.

Open in Search →

A study to compare the effect of AVT16 and Entyvio® in subjects with moderate to severe active ulcerative colitis. Ended

2023-507705-34-00 5 2025-08-29 Moderate to Severe Active Ulcerative Colitis
KONFIDENT-KID Ended

2023-507591-44-00 5 2024-10-24 Hereditary Angioedema Type I or II
A study of aficamten (CK-3773274) in adults with symptomatic non-obstructive hypertrophic cardiomyopathy (ACACIA) Ended

2023-505797-15-00 5 2024-09-13 SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
Efficacy and Safety of Rosnilimab in Subjects with Ulcerative Colitis Ended

2023-508679-34-00 4 2024-07-30 Ulcerative Colitis
A Phase 3, Placebo-controlled, Cross-over Study of Oral Deucrictibant Soft Capsule for On-Demand Treatment of Attacks in Adolescents and Adu … Ended

2023-507268-37-00 5 2024-07-29 Hereditary Angioedema
CSL312_3003 Safety and Pharmacokinetic study in Subjects 2 to 11 Years of Age with Hereditary Angioedema Ended

2022-502386-13-00 5 2024-05-10 Hereditary angioedema (HAE)
MYK-224 in Heart Failure with Preserved Ejection Fraction (HFpEF) Ended

2023-505919-21-00 4 2024-04-25 Heart failure with preserved ejection fraction (HFpEF)
A Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis Ended

2023-505841-22-00 5 2024-04-04 Moderate to Severe Plaque Psoriasis
ABTECT-1 – ABX464 Treatment Evaluation for ulcerative Colitis Therapy -1 Ended

2022-500535-36-01 5 2023-06-12 Moderately to severely active ulcerative colitis
A long-term study to evaluate if KVD900 is safe and effective in treating attacks in patients with Hereditary Angioedema. Ended

2023-505904-41-00 5 2022-11-17 Hereditary Angioedema Type I or II
PROgnostic value of precision medicine in patients with Myocardial Infarction and non-obStructive coronary artEries: the PROMISE study Ended

2024-518724-72-00 6 2021-09-02 Myocardial infarction with non-obstructive coronary arteries (MINOCA)
Perioperative treatment of locally advanced resectable gastric or GEJ adenocarcinoma Ended

2023-509595-42-00 5 2017-10-31 Gastric and gastroesophageal junction (GEJ) adenocarcinoma

Showing 49–60 of 60 trials